Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer

By Vandana Singh
March 27, 1:23 PM
Germany’s Merck KGaA (OTC: MKGAF) (OTC: MKKGY) has regained exclusive worldwide rights to develop, manufacture, and commercialize its checkpoint blocker Bavencio (avelumab) from Pfizer Inc (NYSE:PFE).…

M

Read More
4 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • Markets
  • Media
  • News
  • Penny Stocks
  • Tech
  • Top Stories

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today’s Top Stories

By Vandana Singh
March 27, 11:00 AM
Benzinga

BBIO

Read More
4 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • Markets
  • Media
  • News
  • Penny Stocks
  • Tech
  • Top Stories

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today’s Top Stories

By Vandana Singh
March 27, 11:00 AM
Benzinga

BBIO

Read More
2 minute read
  • Entertainment
  • General
  • Large Cap
  • Media
  • Mid Cap
  • Penny Stocks
  • Small Cap
  • Topics
  • Trading Ideas

Sound Investments: 8 Stocks That Could Help You Get Your Lollapalooza Ticket Money Back

By AJ Fabino
March 27, 9:57 AM
Summer music festivals are back, and Chicago’s Lollapalooza is leading the charge with an impressive lineup of headliners including Kendrick Lamar, Billie Eilish and the Red Hot Chili Peppers.

AAPL

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Why BioNTech Shares Are Trading Lower Today

By Vandana Singh
March 27, 8:09 AM
BioNTech SE (NASDAQ: BNTX) shares are falling in the premarket session today after the company reported Q4 earnings and expected lower annual revenue from the Covid-19 vaccine.

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Why Novartis Shares Are Trading Higher Premarket Today

By Vandana Singh
March 27, 7:54 AM
Novartis AG (NYSE: NVS) shares are trading higher in the premarket session after its breast cancer drug showed clinical benefit in early-stage breast cancer.

LLY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Rumors

Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest

By Vandana Singh
March 27, 7:50 AM
BridgeBio Pharma Inc (NASDAQ: BBIO) is reportedly attracting takeover interest as some large pharmaceutical companies are studying a potential acquisition of the biotech firm. 

BBIO

Read More
3 minute read
  • Large Cap
  • Long Ideas
  • News
  • Short Ideas
  • Trading Ideas

Benzinga Bulls And Bears: Nvidia, Tesla, Block And A Massive Vulnerability Found In Dogecoin’s Code

By Michael Cohen
March 25, 12:40 PM
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 

BAC

Read More
1 minute read
  • Large Cap
  • Media
  • News

Barron’s Top Weekend Stock Picks: Oracle, Costco, Ford And Odds Of Microsoft-Activision Deal Just Got Much Better

By Michael Cohen
March 25, 11:25 AM
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

COST

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Novo Nordisk’s Higher Dose Oral Semaglutide Shows Superior Reductions In Sugar Levels, Body Weight

By Vandana Singh
March 24, 1:37 PM
Novo Nordisk A/S (NYSE:NVO) announced headline results from the PIONEER PLUS phase 3b trial of oral semaglutide 25 mg and 50…

NVO

Posts pagination

Previous 1 … 343 344 345 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service